Cargando…
Evaluating Long-Term Benefits of Chronic Azithromycin. Furthering Our Quest for Precision Medicine
Autores principales: | Saiman, Lisa, Schechter, Michael S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049931/ https://www.ncbi.nlm.nih.gov/pubmed/31810394 http://dx.doi.org/10.1164/rccm.201911-2234ED |
Ejemplares similares
-
Role of long-term azithromycin therapy for severe bronchial asthma
por: Al-Hajjaj, Mohamed S., et al.
Publicado: (2020) -
The Genomic Classifier and Our Quest for Diagnostic Certainty in Interstitial Lung Disease
por: Wong, Alyson W., et al.
Publicado: (2022) -
Further improvements of our journal performance figures
por: Andersson, Arne
Publicado: (2014) -
Further improvement of our metrics—will plan S affect them?
por: Andersson, Arne, et al.
Publicado: (2019) -
Paving the way to precision medicine for diabetic kidney disease: the PRIORITY trial
por: Schechter, Meir, et al.
Publicado: (2020)